A clinical and biochemical study on tissue polypeptide antigen (TPA) in non-malignant hepatic disorders

References

• Björklund B, Björklund V. Antigenicity of pooled malignant and normal tissues by cytoimmunologi-cal technique: Presence of an insoluble, heat-labile tumor antigen. Int Arch Allergy Appl Immunol 1957; 10: 153–84
   PubMedGoogle Scholar
• Björklund B. On the nature and clinical use of tissue polypeptide antigen (TPA). Tumor Diagn 1980; 1: 9–20
   Google Scholar
• Valladares Y. Estado actual de los marcadores biologicos en oncologia. Rev Esp Oncologia 1985; 32: 129–61
   PubMedGoogle Scholar
• Ruibal A, Encabo G, Duran Bellido P, Salgado A, Garcia Bragado F, Aguade S. El antigeno polipep-tidico histico (APH) serico en clinica no oncologica. Estudio de los falsos positivos. Med Clin (Bare) 1984; 82: 514
   PubMed Web of Science ®Google Scholar
• Beham A, Weybora W, Lackinger E, Denk H, Björklund V, Björklund B. Distribution of TPA and cytokeratins in gastrointestinal carcinomas as revealed by immunohistochemistry. Virchows Arch [A] 1986; 409: 641–55
   Web of Science ®Google Scholar
• Luning B, Nilsson V. Sequence homology between tissue polypeptide antigen (TPA) and intermediate filament (IF) proteins. Acta Chem Scand 1983; B37: 731–3
   Google Scholar
• Touitou Y, Bogdan A. Etude critique des marqueurs tumoraux recents. Bull Cancer (Paris) 1988; 75: 247–62
   PubMed Web of Science ®Google Scholar
• Meduri F, Doni M G., Merenda R, Bizzarini M, Neri D, Gerunda G E., Maffei Faccioli A. The role of the leukocyte adherence inhibition (LAI), CA 19–9, and tissue polypeptide antigen (TPA) tests in the diagnosis of pancreatic cancer. Cancer 1989; 64: 1103–6, 9 Kew MC, Berger EL. The value of serum concentrations of tissue polypeptide antigen in the diagnosis of hepatocellular carcinoma. Cancer 1986, 58: 127–30
   PubMed Web of Science ®Google Scholar
• Mross K B., Wolfrum D I., Rauschecker H. Determination of tissue polypeptide antigen (TPA) levels in different cancer types and controls. Oncology 1985; 42: 288–95
   PubMed Web of Science ®Google Scholar
• Buccheri G, Ferrigno D. Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer. Chest 1988; 93: 565–70
   PubMed Web of Science ®Google Scholar
• Fischbach W, Jany B. Neuron-specific enolase in the diagnosis and therapy monitoring of lung cancer: A comparison with CEA, TPA, ferritin and calcitonin. Int J Biol Markers 1986; 1: 129–36
   PubMedGoogle Scholar
• Kanauchi M, Sawai F, Saito T, Yumura F, Kanau-Chi K, Hamaguchi T, Hara Y, Yoshimura K, Nishiura K, Dohi K. Clinical study on tissue polypeptide antigen (TPA) as a tumor marker. Gan No Rinsho 1984; 30: 265–71
   PubMedGoogle Scholar
• Fukazawa I, Inaba N, Ota Y, Sato N, Shirotake S, Iwasawa H, Sato T, Takamizawa H, Wiklund B. Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA 125) and their immunohistochemical identification in benign and malignant gynecological disease. Arch Gynecol Obstet 1988; 243: 41–50
   PubMed Web of Science ®Google Scholar
• Panza N, Pacilio G, Campanella L, Peluso G, Bat-Tista C, Amoriello A, Utech W, Vacca C, Lombardi G. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma. Cancer 1988; 61: 76–83
   PubMed Web of Science ®Google Scholar
• Nicolini A, Carpi A, Di Marco G, Giuliani L, Giordani R, Palla S. A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients. Cancer 1989; 63: 2037–46
   PubMed Web of Science ®Google Scholar
• Coda C, Lanza E, Ciambellotti E, Cartia G L., Moro G. Andamento del dosaggio sierico di quat-tro markers tumorali in corso di epatite virale. Minerva Med 1987; 78: 1577–81
   PubMedGoogle Scholar
• Putzki H, Ledwoch J, Student A, Jablonski M, Heymann H. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases. J Surg Oncol 1988; 37: 133–5
   PubMed Web of Science ®Google Scholar
• Polterauer P, Legenstein E, Muller M. Serumkon-zentrationen von tissue polypeptide antigen und al-phal-fetoprotein bei patienten mit primarem leberkarzinom, metastasenleber und leberzirrhose. Wien Klin Wochenschr 1985; 97: 417–20
   PubMed Web of Science ®Google Scholar
• Gallo V, Cerutti E, Riberi A, Re M, Petrino R, Pecchio F. Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders. J Nucl Med Allied Sci 1989; 33(3 Suppl)89–93
   PubMedGoogle Scholar
• Sabbatani S, Monti M, Fini A. Tissue polypeptide antigen (TPA) modifications in hepatic cirrhosis, aggressive chronic hepatitis, persistent chronic hepatitis, and in minimal pathology. Int J Biol Markers 1988; 3: 127–8
   PubMedGoogle Scholar
• Sabbatani S, Monti M, Turba E, Fini A, Falcone F. Use of TPA in hepatology of infectious nature. Initial observations. Nucl Med Commun 1986; 7: 137–41
   PubMed Web of Science ®Google Scholar
• Ricci G, Berlanda G, Guolo P, Dalla Pria A F. Role of tissue polypeptide antigen (TPA) in the diagnosis of carcinoma. Sixth Annual Meeting of the Italian Society of Oncology Surgery. Italian Society of Oncology Surgery, PaduaItaly 1982; 146
   Google Scholar
• Maussier M L., Valenza V, Schinco G, Galli G. AFP, CEA, CA 19–9 and TPA in hepatocellular carcinoma. Int J Biol Markers 1990; 5: 121–6
   PubMedGoogle Scholar
• Leandro G, Zizzari S, Piccoli A, Manghisi O G. The serum tissue polypeptide antigen in the detection of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 1990; 37: 449–51
   PubMedGoogle Scholar
• Burt A D., Steward J A., Aitchison M, MacSween R NM. Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: changes in liver disease. J Clin Pathol 1987; 40: 719–24
   PubMed Web of Science ®Google Scholar
• Piaserico P, Guolo P, Dalla Pria A F., Ricci G, Berlanda G, Florian G, Forin M. L'antigene polipeptidico tessutale: Significato e prospettive di impiego nel laboratorio clinico. Quad Sclavo Diagn 1985; 21: 154–62
   PubMedGoogle Scholar